- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01253759
Long Term Results of Combined Transpupillary Thermotherapy (TTT) Indocyanine Green (ICG) Based Photodynamic Therapy (PDT) in Choroidal Melanoma
May 1, 2013 updated by: Peter E. Liggett, New England Retina Associates
10 Years Report of Combined Simultaneous Transpupillary Thermotherapy and ICG-based Photodynamic Therapy for Choroidal Melanoma
This is a report of 10 years results of combined Transpupillary thermotherapy (TTT) treatment with Indocyanine green (ICG) in controlling small and medium-sized choroidal melanomas.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The study was done in a Clinical practice setting.
Forty six eyes of 46 patients with small or medium-sized choroidal melanomas were treated with i-TTT using infrared light delivered from a diode laser.
All patients were evaluated to rule out systemic metastasis and underwent a complete ophthalmological evaluation including: Slit lamp biomicroscopy, dilated fundus examination, Fluorescein angiography, Optical coherence tomography and A/B ultrasonography.
Main outcome measures were: Changes in visual acuity, complications associated with the treatment and local control of the tumor.
Study Type
Observational
Enrollment (Actual)
46
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Connecticut
-
Hamden, Connecticut, United States, 06518
- New England Retina Associates
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 95 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Subjects selected from retina specialist general patient population.
Description
Inclusion Criteria:
- Small and medium-sized choroidal melanoma
- Patients older than 18 years old.
- Patients who can read and signed the informed consent.
Exclusion Criteria:
- Patients with ocular inflammation.
- Patients with another active ocular disease.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
1
Combined treatment of Transpupillary Thermotherapy and ICG-based photodynamic therapy (PDT)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Peter E Liggett, MD, New England Retina Associates
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2009
Primary Completion (Actual)
January 1, 2009
Study Completion (Actual)
March 1, 2009
Study Registration Dates
First Submitted
March 25, 2009
First Submitted That Met QC Criteria
December 2, 2010
First Posted (Estimate)
December 3, 2010
Study Record Updates
Last Update Posted (Estimate)
May 3, 2013
Last Update Submitted That Met QC Criteria
May 1, 2013
Last Verified
May 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NERA-2
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Choroidal Melanoma
-
Aura BiosciencesCompletedOcular Melanoma | Uveal Melanoma | Choroidal MelanomaUnited States
-
Aura BiosciencesActive, not recruitingOcular Melanoma | Uveal Melanoma | Choroidal MelanomaUnited States
-
Jonsson Comprehensive Cancer CenterCompleted
-
Jonsson Comprehensive Cancer CenterCompletedOcular Melanoma | Uveal Melanoma | Choroidal MelanomaUnited States
-
New England Retina AssociatesCompletedChoroidal MelanomaUnited States
-
New England Retina AssociatesGenentech, Inc.CompletedChoroidal MelanomaUnited States
-
Institut CurieCompleted
-
Institut CurieCompletedChoroidal Melanoma, DiffuseFrance
-
Aura BiosciencesTerminatedChoroidal Melanoma | Indeterminate LesionsUnited States
-
Aura BiosciencesRecruitingChoroidal Melanoma | Indeterminate Lesions of EyeUnited States
Clinical Trials on TTT + ICG-based PDT
-
VA Office of Research and DevelopmentCompletedStroke | HemiparesisUnited States
-
New England Retina AssociatesCompletedChoroidal MelanomaUnited States
-
King Saud UniversityCompleted
-
Washington University School of MedicineCompletedMelanoma | Breast Cancer | Malignant Melanoma | Cancer of Breast | Cancer of the BreastUnited States
-
Medical University of ViennaRecruitingAge Related Macular DegenerationAustria
-
Massachusetts General HospitalNational Cancer Institute (NCI); Jawaharlal Nehru Medical CollegeCompleted